StockData

Agilent Technologies vs Roper Technologies

A and ROP side by side, both in laboratory apparatus and analytical, optical, measuring, and controlling instruments. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How A and ROP compare

Agilent Technologies and Roper Technologies are about the same size, with market caps of $49.3B and $46.1B.

On earnings, Roper Technologies is cheaper: it trades at 19.3× trailing earnings, against 34.5× for Agilent Technologies.

Roper Technologies grew revenue faster over the last twelve months (10.9% versus 8.6% for Agilent Technologies).

Roper Technologies keeps more of each dollar of sales as profit, with a net margin of 30.2% compared with 19.5% at Agilent Technologies.

Both pay dividends: Agilent Technologies yields 0.58% and Roper Technologies 0.78%.

Agilent Technologies scores higher on the StockData Score (21 against 19 for Roper Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAROP
Size and price
Market cap$49.3B$46.1B
Share price$174.87$466.60
Change, 1 year22.1%4.6%
Change, 5 years11.8%−3.7%
Beta (5Y)1.040.75
Employees18K19K
StockData Score
Total score21 (better)19
Valuation score16 (better)
Growth score44
Performance score6 (better)3
Health score6 (better)3
Dividend score4 (better)3
Valuation
P/E34.5×19.3× (better)
P/S6.7×5.6× (better)
P/B6.7×2.5× (better)
EV/EBITDA25.1×24.7× (better)
P/FCF38.9×–
PEG11.43–
FCF yield2.6%–
Fair value$149.03$627.18
Margin of safety−17.3%25.6% (better)
Growth
Revenue growth (TTM)8.6%10.9% (better)
Revenue growth, 5Y average5.4%14.5% (better)
Net income growth (TTM)18.0%62.7% (better)
EPS growth (TTM)18.7%69.6% (better)
EPS growth, 5Y average14.7% (better)9.6%
Profitability
Gross margin53.8%69.5% (better)
Operating margin22.2%28.0% (better)
Net margin19.5%30.2% (better)
FCF margin17.2%–
Return on equity21.0% (better)13.1%
Return on invested capital26.4% (better)6.7%
Financial health
Debt / equity0.04 (better)0.61
Net debt / EBITDA−0.764.73 (better)
Interest coverage15.5× (better)5.9×
Current ratio2.05 (better)0.55
Altman Z-score5.79 (better)2.83
Piotroski F-score55
Dividends and buybacks
Dividend yield0.58%0.78% (better)
Payout ratio19.9%14.7%
Years of dividend growth1014 (better)
Dividend growth, 5Y average6.6%10.1% (better)
Buyback yield0.77%–
Shareholder yield1.4% (better)0.78%
Ownership
Held by institutions92.8%103%
Held by insiders0.29%0.37%
Insider net buying, 12 months−$3.2M (better)−$13.5M
Superinvestors holding33
Short interest, % of float1.9%4.6%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.